Associate Professor
Duke University
Cary, North Carolina, United States
Jonathan Campbell is an Associate Professor in the Duke Molecular Physiology Institute at Duke University. His group studies how gut-derived peptides such as GLP-1 and GIP regulate metabolism through actions in the pancreatic islet. This work aims to better understand how GPCRs in pancreatic islets cells regulate insulin and glucagon secretion, and how the paracrine interactions between islets cells mediate hormone secretion and metabolic homeostasis. This work is supported by funding from the American Diabetes Association, the NIH, the Helmsley Foundation, Eli Lilly, Merck, and Novo Nordisk.
DC2415 - Advancing Diabetes Treatment: The Future of GPCR-Targeted Therapies
Friday, November 22, 2024
11:30 - 12:45 AT Time
Disclosure(s): Altimmune: Advisory Board (Ongoing); Arrowhead Therapeutics: Advisory Board (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing); Eli Lilly & Company: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); Neurocrine: Board Member (Ongoing); novo nordisk: Grant/Research Support (Ongoing); Prostasis: Board Member (Ongoing); Septerna: Advisory Board (Ongoing); Structure Therapeutics: Advisory Board (Ongoing)